DCGO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DocGo Inc (DCGO) is not a good buy for a beginner, long-term investor at this time. The company is facing significant challenges in scaling its Mobile Health business and improving profitability, as highlighted by analysts. The technical indicators are mixed, with bearish moving averages and neutral RSI, while the options data shows low put-call ratios, indicating limited trading interest. Additionally, the company's financial performance in the latest quarter shows a sharp revenue decline and negative profitability, which are concerning for long-term investment. Without strong positive catalysts or clear signs of improvement, it is better to hold off on investing in DCGO for now.
The MACD histogram is positive and expanding, indicating slight bullish momentum. However, the RSI is neutral at 54.959, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level (R1: 0.592), which could limit further upward movement. Key support levels are at S1: 0.509 and S2: 0.483.
NULL identified. No recent news or events suggest a positive catalyst for the stock. Analysts note a potential strategic alternative process, but no concrete outcomes have been reported.
Mixed Q4 results with significant revenue decline (-37.98% YoY) and ongoing challenges in scaling the Mobile Health business. Analysts have lowered price targets, and the company has yet to achieve profitability.
In Q4 2025, revenue dropped by 37.98% YoY to $74.94M. Net income increased significantly to -$134.07M (up 4009.06% YoY), but this reflects worsening losses. EPS also increased negatively to -1.37 (up 4466.67% YoY). Gross margin dropped to 27.25%, down 11.44% YoY, indicating declining operational efficiency.
Analysts are cautious. Canaccord lowered its price target to $1 from $1.50 with a Hold rating, citing challenges in scaling the Mobile Health business. Stifel lowered its price target to $2.50 from $4 but maintains a Buy rating, citing potential value in the transport segment. Overall, sentiment is mixed but leans negative.
